ATryn (GTC Biotherapeutics, Inc.)
Welcome to the PulseAid listing for the ATryn drug offered from GTC Biotherapeutics, Inc.. This Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GTC Biotherapeutics, Inc. |
| NON-PROPRIETARY NAME: | Antithrombin (Recombinant) |
| SUBSTANCE NAME: | ANTITHROMBIN ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-05-06 |
| END MARKETING DATE: | 0000-00-00 |
ATryn HUMAN PRESCRIPTION DRUG Details:
| Item Description | ATryn from GTC Biotherapeutics, Inc. |
| LABELER NAME: | GTC Biotherapeutics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1750([iU]/1) |
| START MARKETING DATE: | 2009-05-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42976-121_ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1 |
| PRODUCT NDC: | 42976-121 |
| APPLICATION NUMBER: | BLA125284 |
Other ANTITHROMBIN ALFA Pharmaceutical Manufacturers / Labelers:
